# Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

> **NCT01294358** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 7 (actual)

## Conditions studied

- Histologically or Cytologically Confirmed Pancreatic Ca
- Unresectable or Borderline Resectable Pancreatic Ca

## Interventions

- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT01294358
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-26
- **Primary completion:** 2014-07-23
- **Final completion:** 2014-07-23
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294358, "Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01294358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*